Remove companies pfizer-inc
article thumbnail

“Federal Judges or Their Brokers Traded Stocks of Litigants During Cases; Dozens of judges have reported share purchases and sales made while they presided in suits involving those companies, a WSJ investigation found”

HowAppealing

“Federal Judges or Their Brokers Traded Stocks of Litigants During Cases; Dozens of judges have reported share purchases and sales made while they presided in suits involving those companies, a WSJ investigation found”: Coulter Jones, Joe Palazzolo, and James V. reported nearly a dozen buys and sells of Pfizer Inc.

article thumbnail

Surely You Must be Kidding, PTO?!? “No, and Don’t Call Me Shirley!” – The Seemingly Slapstick (But Yet Unfunny) World of Recent Patent Term Extension Decisions (PART 3. and PART 3½)

FDA Law Blog

1.750, applicant is required to submit the following to the USPTO: Evidence that Genmab A/S is expressly authorized to rely upon the regulatory review activities by Genmab US, Inc., According to the PTE application, however, the “Marking Applicant for EPKINL Y® ( epcoritamab-bysp) is Genmab US, Inc., Biogen MA Inc. Lehman , No.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pfizer's $5.4B Deal To Acquire Drugmaker Faces Investor Suit

Law 360

Global Blood Therapeutics Inc. investors have challenged Pfizer's $5.4 billion plan to acquire the sickle cell-drug company, claiming that GBT's top brass made incomplete and misleading disclosures in an attempt to convince shareholders to sign off on the proposed deal.

40
article thumbnail

COVID-19 Vaccine Scammers Find Victims Around the World

The Crime Report

Some of the governments were offered vaccines from Pfizer Inc. An unidentified government agency was offered 20 million Pfizer-BioNTech doses for $751 million. and partner BioNTech SE, Johnson & Johnson as well as AstraZeneca PLC. Investigators at the U.S. and overseas.